Rhenman & Partners Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-62,517
| Closed | -$3.01M | – | 95 |
|
|
2015
Q1 | $3.01M | Hold |
62,517
| – | – | 0.51% | 67 |
|
|
2014
Q4 | $2.08M | Hold |
62,517
| – | – | 0.6% | 73 |
|
|
2014
Q3 | $1.83M | Sell |
62,517
-4,809
| -7% | -$141K | 0.54% | 79 |
|
|
2014
Q2 | $2.62M | Buy |
67,326
+3,900
| +6% | +$152K | 0.78% | 48 |
|
|
2014
Q1 | $2.66M | Buy |
63,426
+2,512
| +4% | +$105K | 0.8% | 45 |
|
|
2013
Q4 | $2M | Buy |
+60,914
| New | +$2M | 0.78% | 57 |
|